Ascelia Pharma AB's total assets for Q3 2025 were kr136.41M, a decrease of ― from the previous quarter. SE:ACE total liabilities were kr22.01M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.